.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Dreamt's performance across various categories in New Jersey shows a mixed trajectory. In the Edible category, Dreamt did not rank in the top 30 in October 2025, indicating a potential decline or shift in consumer preferences. However, by November 2025, the brand re-entered the rankings at 55th place, although this is still outside the top 30, suggesting room for improvement. Despite the fluctuations in ranking, the sales figures reveal a notable increase in September compared to August, before dropping again in November, hinting at possible seasonal or promotional influences.
In contrast, Dreamt's performance in the Tincture & Sublingual category in New Jersey appears to be more promising. The brand secured a 5th place ranking in November 2025, marking a significant presence in this category. This strong positioning, without data from the preceding months, suggests a recent surge in popularity or a successful product launch. The lack of earlier rankings could indicate that Dreamt was not previously in the top 30, which makes the November ranking particularly noteworthy. This performance disparity between categories highlights Dreamt's potential to capitalize on specific segments within the market.
Competitive Landscape
In the competitive landscape of the New Jersey edible cannabis market, Dreamt has experienced fluctuating rankings and sales over the past few months. Despite a slight improvement from 48th to 49th place between August and September 2025, Dreamt was absent from the top 20 rankings in October, before reappearing in 55th place by November. This suggests a challenging period for the brand, especially when compared to competitors like Kynd Cannabis Company, which, although also not in the top 20, maintained a higher rank in the 30s before dropping out of the top 50 by November. Meanwhile, HAZE and HAMSA Edibles have shown more consistent performance, with HAZE even reaching the 38th position in September. The entry of Brute's Roots into the rankings in October, climbing to 49th by November, indicates increasing competition. Dreamt's sales have seen a decline from September to November, contrasting with the more stable or growing sales figures of its competitors, highlighting the need for strategic adjustments to regain market share.
Notable Products
In November 2025, the top-performing product for Dreamt was the CBD/THC 2.5:1 Sleep Tincture (60mg CBD, 150mg THC, 60ml) from the Tincture & Sublingual category, which climbed to the number one rank with sales reaching 895 units. The CBD/THC/CBN 2:5:1 Honey Lemon Gummies 20-Pack, an Edible, slipped to the second position after maintaining the top spot for three consecutive months prior. The For Sleep CO2 Disposable Pen, a new entrant in the Vapor Pens category, made a notable debut at the third rank. The Honey Lemon Soft Lozenge 20-Pack, also an Edible, dropped to fourth place, continuing its declining trend in sales over the past months. Lastly, the CBD/THC/CBN 2:5:1 Honey Lemon Gummies 2-Pack, another Edible, did not rank in November, following a decrease in sales since its introduction in September.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
